Combo Product RFDs Should Anticipate Company Pipeline – Attorney
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers considering a request for designation (FRD) submission to FDA for a combination product should bear in mind how an RFD may affect next-generation products, according to Morgan, Lewis & Bockius attorney Kathryn Gleason